Recent News

• 04.21.2025 - A Human Histidyl-tRNA Synthetase Splice Variant Therapeutic Targets NRP2 to Resolve Lung Inflammation and Fibrosis
• 04.17.2025 - Piper Sandler Spring Biopharma Symposium
• 04.17.2025 - Piper Sandler Spring Biopharma Symposium
• 04.08.2025 - April 8, 2025 - April 9, 2025 : Jones Healthcare and Technology Innovation Conference
• 04.08.2025 - April 8, 2025 - April 9, 2025 : Jones Healthcare and Technology Innovation Conference
• 04.07.2025 - Dalia R. Rayes
• 04.03.2025 - aTyr Pharma to Participate in April Investor Conferences
• 04.03.2025 - aTyr Pharma to Participate in April Investor Conferences
• 04.03.2025 - aTyr Pharma to Participate in April Investor Conferences
• 03.27.2025 - aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

• 03.19.2025 - DEF 14A Other definitive proxy statements
• 03.19.2025 - ARS Annual Report to Security Holders
• 03.19.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 03.17.2025 - 4 Statement of changes in beneficial ownership of securities